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Abstract
Campylobacter jejuni is a leading cause of foodborne illness worldwide, mainly due to consumption and handling of contam-
inated raw chicken. Rapid detection methods for C. jejuni are vital for monitoring contamination levels in chicken products and
reducing humanCampylobacteriosis cases. The ‘gold standard’ culture-basedmethod ofCampylobacter detection takes 3–5 days
and is too slow to permit effective intervention. Immuno-based methods are faster, but usually necessitate use of animals or
hybridoma technology to produce antibodies; making them difficult and expensive to produce. Here, we report the generation
and characterization of recombinant single-chain variable fragment (scFv) antibodies specific forC. jejuni cells, and evaluation of
one scFv antibody for an immunomagnetic separation-quantitative PCR (IMS-qPCR) method to rapidly, sensitively, and specif-
ically detect low numbers ofC. jejuni. An scFv antibody phage-display library was constructed using spleenmRNA derived from
a rabbit immunized with gamma-irradiated C. jejuni cells. This library was screened by surface biopanning against C. jejuni
whole cells. Enriched clones were analyzed by enzyme-linked immunosorbent assay (ELISA). Two scFv antibodies that strongly
and specifically recognized C. jejuni cell were expressed in Escherichia coli. Western blot analysis showed that one antibody,
scFv80, was expressed as a soluble protein and retained its specific and strong binding to C. jejuni cells. This recombinant
monoclonal scFv antibody was purified and used to covalently coat paramagnetic beads to be used for IMS-qPCR. The IMS-
qPCR method was able to specifically and sensitively detect C. jejuni in mixed cultures within 3 h.
Keywords Campylobacter jejuni . Recombinant scFv antibody . Immunomagnetic separation (IMS) . Detection specificity .
Phage display
Introduction
Campylobacter, especially C. jejuni, is one of the leading
causes of bacterial foodborne illnesses worldwide (Silva
et al. 2011; Tram et al. 2012). In the industrialized coun-
tries, Campylobacter spp. are the most common cause of
foodborne illness in humans, ahead of Salmonella (Food
Standards Agency 2009; Dominguez 2012). Data on
Campylobacteriosis from developing countries is scarce,
but there is a suggestion that the human burden due to
Campylobacter infection is considerable (World Health
Organization 2012; Platts-Mills and Kosek 2014).
Mishandling of contaminated raw chicken and consump-
tion of undercooked poultry have been incriminated as the
most significant source of C. jejuni infections for humans
(Tam et al. 2009; Sheppard et al. 2009; Dominguez 2012).
Campylobacter is a harmless commensal intestinal inhabitant
of chicken (Doyle 1994), which makes it difficult to spot early
infection of Campylobacter in a flock. It spreads quickly and
95% of a flock of 20,000 chickens can be infected by
Campylobacter within 4 to 7 days after colonization of the
first bird (Van Gerwe et al. 2009). Cross contamination of
broiler carcasses can also occur in the slaughterhouse
(Hermani et al. 2003; Tram et al. 2012). A significant corre-
lation between the contamination of the broilers during rearing
and the carcasses after processing has been observed
(Hermani et al. 2003).
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There is a need tomonitorCampylobacter during the life of
the chickens in broiler houses, to spot the infection as early as
possible and to determine effectiveness of interventions. In the
slaughter house, Campylobacter infection status needs to be
checked in order to schedule flocks for slaughtering and pre-
vent cross contamination (Tram et al. 2012). However, such
monitoring has been hampered by the current ‘gold standard’
culture-based detection method, ISO/TS/EN 10272-2:2006
(International Standards Organization 2006). This method
generally require 24–48 h enrichment culture before isolation
ofC. jejuni on selective culture media. Enrichment is followed
by confirmatory methods such as biochemical and serological
tests (Goossens and Butzler 1992), DNA/RNA hybridizations
(Cudjoe et al. 1991; Ransom et al. 1994), enzyme-linked im-
munosorbent (ELISA) assay (Haas 1997), randomly ampli-
fied polymorphic DNA (RAPD) analysis (Mazurier et al.
1992; Hilton et al. 1997), polymerase chain reaction (PCR)
or quantitative PCR (qPCR) assays (Giesendorf et al. 1992;
Sails et al. 2003), and loop-mediated isothermal amplification
(LAMP) of DNA (Yamazaki et al. 2009). Combination of
culture enrichment procedure with these confirmatory
methods leads to 3–5 day detection time, which is too long,
bearing in mind the 4–7 day flock infection rate. By the time
the results become available, the status of the flock may have
changed, which may result in a false negative flock status.
Another limitation of culture enrichment-dependent methods
is their inability to detect viable but non-culturable (VBNC)
Campylobacter cells that may be able to regenerate and be-
come infectious again (Rollins and Colwell 1986; Silva et al.
2011). Direct detection of Campylobacter by PCR and qPCR
methods without culture enrichment has been published
(Rasmussen et al. 1996; Bang et al. 2001; Vondrakova et al.
2014). However, sensitive, specific, and rapid PCR detection
can be hampered by inhibitors present in the crude sample
matrix leading to false negative results (Tram et al. 2012).
The other limitation of all the described culture-based
methods is that only a very small portion (10–500 μl) of the
considerable volume of biological samples (50–250 ml) is
actually tested; this may also lead to false negative results,
given that the abundance of Campylobacter spp. in biolog-
ical samples may be low. Detection sensitivity of tests for
Campylobacter spp. could be substantially improved if
most of the Campylobacter cells in the large initial volume
of sample could be concentrated into a small volume prior
to testing.
To by-pass culture enrichment, immunomagnetic separa-
tion (IMS) methods have previously been developed using
polyclonal (pAb) or monoclonal (mAb) antibodies to capture
Campylobacter cells from milk, chicken meat, and chicken
feces (Docherty et al. 1996; Lamoureux et al. 1997; Yu et al.
2001; Tram et al. 2012). IMS concentrates the target bacterial
cells, thus reducing the sample volume, and removes sample
constituents that may interfere with subsequent PCR; hence,
the sensitivity of the assay is increased. However, production
of appropriate antibodies is often time consuming, laborious,
and expensive. pAbs can be only generated in limited
amounts, dependent on animal size. The advent of hybridoma
technology ushered in production of mAbs with defined
antigen specificity and enables long-term antibody supply
(Köhler and Milstein 1975; Lipman et al. 2005). However,
the conventional hybridoma approach, which requires
animal cell culture, is every expensive (Nelson et al.
2000). The clones produced also tend to lose antibody-
secreting ability over time (Singh et al. 2010), limiting
continuous supply.
Recombinant DNA technology has made it possible to
generate monoclonal single-chain variable fragment (scFv)
antibodies as recombinant proteins in Escherichia coli
(Skerra and Pluckthun 1988). The scFv antibodies are a min-
imal form of functional antibodies which preserve the binding
specificity of the parental IgG antibodies (Hagemeyer et al.
2009). A large repertoire of diverse scFv-libraries is construct-
ed from RNA isolated from spleenocytes or the bone marrow
of a host previously immunized with an antigen (Barbas et al.
2001). cDNA fragments coding variable heavy (VH) and var-
iable light (VL) chains are amplified from the RNA by RT-
PCR and randomly joined by overlap PCR. The resulting full-
length scFv cDNA fragments are then cloned into a suitable
expression vector to express the scFv antibodies. Their small
size makes cloning into E. coli expression vectors easy,
resulting in the ability to produce large quantities of monoclo-
nal scFv antibodies quickly in bacterial cultures at a relatively
low cost. The cloned fragments can be genetically engineered,
if desired, e.g., to further optimize specificity and affinity
(Hagemeyer et al. 2009).
Phage display is the most efficient system of expressing
and screening recombinant scFv antibodies (Barbas et al.
2001). To this end, the full-length scFv cDNA fragments are
cloned into phagemid vectors and introduced into E. coli cells
to produce phage particles. The resultant display of the scFv
antibody on the surface of the bacteriophage particle has been
utilized as a means for effective screening for monoclonal
scFv antibodies of desired specificity by phage biopanning
(Barbas et al. 2001). Biopanning of scFv phage display librar-
ies has been used to provide scFv antibodies against many
antigens including foodborne contaminants Listeria
monocytogenes (Paoli et al. 2007), staphylococcal enterotoxin
B (SEB) (Singh et al. 2010), Salmonella Typhimurium
(Meyer et al . 2012), and T3SS needle of Vibrio
parahaemolyticus (Wang et al. 2014). However, to our knowl-
edge, no recombinant anti-Campylobacter scFv antibodies
have been reported to date.
In this study, recombinant rabbit scFv antibodies exhibiting
specific binding to C. jejuni cells were constructed and select-
ed by phage display technology. One of these anti-C. jejuni
recombinant scFv antibodies was expressed in E. coli and
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purified. It was then coupled to tosylactivated paramagnetic
beads to successfully capture C. jejuni cells in a specific and
sensitive manner by IMS.
Material and methods
Preparation of irradiated C. jejuni cells
Campylobacter jejuniATCC 29428 was cultured on Columbia
Blood agar with 5% horse blood (Oxoid, Basingstoke,
England) for 48 h at 42 °C under microaerophilic conditions.
Cells were harvested and washed three times in phosphate
buffer saline (PBS). The final pellet was resuspended in PBS
to OD600 1.0. Aliquoted cells were then gamma (γ)-irradiated
with a dose of 10 kGy using a Gammabeam 650 cobalt irradi-
ator (located at Agri-Food and Biosciences Institute for
Northern Ireland, Newforge Lane, Belfast, Northern Ireland)
and stored at − 80 °C to be used as the whole cell antigen
(WCA) for antibody production and phage display biopanning
purposes.
Rabbit immunizations
Two New Zealand White rabbits (Q1 and Q2) were hyper-
immunized with 109 cfu/ml of γ-irradiated C. jejuni WCA.
In total, 1 ml of WCAwas mixed with 1 ml of mineral oil and
administered to each rabbit in six injections over a 4-month
period with 2-week intervals between the first and second
injections, and then 4-week intervals subsequently. Blood
was taken 10 days after each of the first five immunizations
and titered by indirect enzyme-linked immunosorbent assay
(ELISA) to determine presence of C. jejuni-specific
antibodies.
Total RNA extraction and cDNA synthesis
Fourteen days after the final immunization, rabbit Q1 was
euthanized and exsanguinated. Spleen was harvested into
RNALater (Thermo Scientific). Total RNA was extracted
using 3 ml of TRI-reagent (Thermo Scientific) per 100 mg
of tissue, following the manufacturer’s instructions. The
RNA samples were then treated with DNase using TURBO
DNA-free™ Kit (Ambion) to remove traces of DNA.
Concentration of the RNA samples was quantified using
NanoDrop™-2000, and 500 ng of RNAwas checked by aga-
rose gel electrophoresis to confirm no degradation of RNA.
Five micrograms of total RNA purified from the rabbit spleen
was used to synthesize first-strand cDNA using the
SuperScript III First-Strand Synthesis System (Invitrogen) ac-
cording to the manufacturer’s instructions.
Generation of rabbit scFv cDNA library
First-strand cDNA derived from immune rabbit spleen was
used to amplify scFv cDNA fragments with an overlap, 7-
amino-acid (GGSSRSS), short linker (SL) sequence for
diabody formation in two PCR steps using a procedure
adapted from Barbas et al. (2001). In the primary PCR,
cDNA fragments encoding the variable light (VL) chains
(VK and Vλ) and the variable heavy (VH) chains were ampli-
fied separately. Using primers in Table 1, nine reactions were
performed by pairing the three VK 5′ forward primers with
each of the three VK 3′ reverse primers, to amplify the
350 bp VK cDNA fragments; one reaction with Vλ 5′ forward
primer RSCλ1 and Vλ 3′ reverse primer RJλo-B to amplify the
350 bp Vλ cDNA; and four reactions by paring each of the
four VH 5′ forward primers with the VH 3′ reverse primer
RSCG-B to amplify the 450 bp VH cDNA. After PCR, VL
and VH cDNA pools were separately made by combining the
10 VL and 4 VH PCR products. After primary purification
using ethanol precipitation, the cDNA fragments encoding
the VL and the VH, respectively, were purified from a 1.5%
agarose electrophoresis gel. These two fragments were mixed
in equal molar ratios and used as the template in the secondary
overlap extension PCR to amplify the full-length scFv cDNA
fragments using primers RSC-F and RSC-R (Table 1). The
assembled 800 bp full-length scFv cDNA fragment was puri-
fied by ethanol precipitation, resolved in a 1% agarose gel,
and purified from gel bands.
pComb3XSS phagemid vector (obtained from Barbas lab,
The Scripps Research Institute, CA; http://www.scripps.edu/
barbas/) and the full-length scFv cDNA fragment were
digested with SfiI (Thermo Scientific), gel purified, and ligat-
ed using T4 DNA ligase, after dephosphorylation of the vec-
tor. Ligation product was purified by ethanol precipitation and
resuspended in 15 μl water. Then 15 electroporations were
performed; each transformed 1μl of the purified ligation prod-
uct into 25 μl E. coli ER2738 electrocompetent cells (Lucigen
Corporation, USA). The transformed E. coli ER2738 cells
were titered on Luria-Bertani (LB) agar plates with 100 mg/
L carbenicillin to determine the number of independent clones
in the library.
Production of scFv displaying phage particles
To produce a library of phage particles displaying scFv, the
transformed E. coliER2738 scFv cDNA library was amplified
and infected with helper phage M13K07 (Barbas et al. 2001).
After overnight infection, the phage particles were harvested
by polyethylene glycol (PEG) precipitation and resuspended
in 2 ml 1% bovine serum albumin (BSA) in Tris-buffered
saline (TBS) (50 mM Tris-HCl (pH 7.5), 150 mM NaCl),
supplemented with 0.02% sodium azide (NaN3), to kill resid-
ual E. coli and prevent microbial growth, then filtered through
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a 0.2 μm syringe filter. The concentration of the phages in
library was determined by titering, before storage at 4 °C.
Prior to biopanning, the phage library was re-amplified as
per Barbas et al. (2001). Only phage library freshly prepared
on the same day was used for biopanning.
Biopanning of phage displayed antibody library
The phage library was biopanned against irradiated C. jejuni
WCA, in order to select anti-C. jejuni scFv displaying phages,
that bound to C. jejuni cells with high affinity, using surface
panning. Eight wells of a 96-well Nunc Maxisorp round-
bottom microtiter plate (Thermo Scientific) were each coated
with 100 μl C. jejuni WCA (1 × 109 cfu/ml) in 0.1 M
NaHCO3 buffer pH 8.6. The coated wells were blocked with
300 μl PBS containing 5% skimmed milk (5% PBSM) and
washed twice with TBS with 0.05% Tween 20. Then, 100 μl
freshly prepared starting phage library containing 6.8 × 107
phages was added into each well and the plate was incubated
at 37 °C for 2 h with gentle rocking. After decanting the phage
solution, each well was washed five times with 200 μl TBS
containing 0.5% Tween 20. The bound phages in each well
were eluted using 100 μl of 100 mM Glycine–HCl pH 2.2
with 1 mg/ml BSA, and neutralized with 6 μl 2 M Tris (pH
9.1). The eluted phages were added into wells coated with C.
jejuni WCA on the second plate and biopanning repeated as
above (a procedure called double recognition, only applied to
this first round biopanning). Eluted phage solutions were neu-
tralized, titered to determine the output, and the rest of the
phages amplified by infecting E. coli ER2738 cells before
being rescued using helper phage M13K07 (Barbas et al.
2001). The amplified phages were titered and used as inputs
for next round of biopanning as above, but with single recog-
nition for all subsequent rounds. In total, six biopanning
rounds were carried out against C. jejuni WCA to enrich the
binding phages.
C. jejuni-binding by the enriched phages from rounds 3 to
6 was analyzed by ELISA.Wells of Nunc-Maxisorp microtiter
plate were coated with irradiated C. jejuniWCA (1 × 107 cfu/
well) and 2.8 × 105 phages were added into each well. Final
anti-serum from rabbit Q1, parental phage that did not display
a scFv, and unpanned phage display library were included as
controls. Uncoated wells were included to assess the back-
ground binding. Bound phages were detected by horseradish
peroxide (HRP)-conjugated anti-M13 monoclonal antibody
(GE Healthcare) and its substrate 2,2′-azino-di[3-ethyl-
benzthiazolin-sulfonate] (ABTS). The bound polyclonal anti-
body from the anti-serum was detected by HRP-conjugated
anti-rabbit IgG (GE Healthcare) and its substrate TMB
(3,3′,5,5′-tetramethybenzidine).
Screening, selection, and characterization of scFv
antibody-display phage clones
The phage clones eluted after round 6 biopanning were titered
and colony PCR was performed to amplify the insert of scFv
cDNA from 135 individual colonies using primers omseq (5′
AAGACAGCTATCGCGATTGCAG 3′) and gback (5′
GCCCCCTTATTAGCGTTTGCCATC 3′) which are locat-
ed either side of the insert. PCR products were subse-
quently digested by Mva I and resolved in a 3% agarose
gel. The clones were grouped according to their cleavage
patterns.
Table 1 Details of PCR primers employed for construction of rabbit scFv fragments. Short linker sequences (GGSSRSS), underlined, are based on
Protocol 9.7, Barbas et al. (2001)
Primer type Primer name Primer ID Primer sequence
Variable Kappa light
chain
Vκ5′ Forward RSCVK1 5′ GGG CCC AGG CGG CCG AGC TCG TGM TGA CCC AGA CTC CA 3′
RSCVK2 5′GGG CCC AGG CGG CCG AGC TCG ATM TGA CCC AGA CTC CA 3′
RSCVK3 5′ GGG CCC AGG CGG CCG AGC TCG TGATGA CCC AGA CTG AA 3′
Vκ 3′ Reverse RKB9J1o-B 5′ GGA AGATCTAGA GGA ACC ACC TTT GAT TTC CAC ATT GGT GCC 3′
RKB9Jo-B 5′ GGA AGATCTAGA GGA ACC ACC TAG GAT CTC CAG CTC GGT CCC 3′
RKB42Jo-B 5′ GGA AGATCTAGA GGA ACC ACC TTT GAC SAC CAC CTC GGT CCC 3′
Variable Lambda
light chain
Vλ 5′ Forward RSCλ1 5′ GGG CCC AGG CGG CCG AGC TCG TGC TGA CTC AGT CGC CCT C 3′
Vλ 3′ Reverse RJλo-B 5′ GGA AGATCTAGA GGA ACC ACC GCC TGT GAC GGT CAG CTG GGT CCC 3′
Variable heavy
chain
VH 5′ Forward RSCVH1 5′ GGT GGT TCC TCTAGATCT TCC CAG TCG GTG GAG GAG TCC RGG 3′
RSCVH2 5′ GGT GGT TCC TCTAGATCT TCC CAG TCG GTG AAG GAG TCC GAG 3′
RSCVH3 5′ GGT GGT TCC TCTAGATCT TCC CAG TCG YTG GAG GAG TCC GGG 3′
RSCVH4 5′ GGT GGT TCC TCTAGATCT TCC CAG SAG CAG CTG RTG GAG TCC GG 3′
VH 3′ Reverse RSCG-B 5´ CCT GGC CGG CCT GGC CAC TAG TGA CTG AYG GAG CCT TAG GTT GCC C 3′
Overlap Overlap Forward RSC-F 5′ GAG GAG GAG GAG GAG GAG GCG GGG CCC AGG CGG CCG AGC TC 3´
Overlap Reverse RSC-B 5′ GAG GAG GAG GAG GAG GAG CCT GGC CGG CCT GGC CAC TAG TG 3′
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The scFv antibodies were targeted against surface epitopes
of C. jejuni whole cells, so representative clones from each
group observed were analyzed for binding capacity to irradi-
ated C. jejuniWCA by phage-binding ELISA. The individual
phage clones were firstly amplified as described above.
Concentration of amplified phage samples was quantified by
quantitative PCR using primers pComb3xss_qPCR.F
(TTTCCGTGTCGCCCTTATTC) and pComb3xss_qPCR.R
(CCCAACTGATCTTCAGCATCTT) and Roche
LightCycler ® 480 SYBR Green I Master. A 96-well
Nunc-Maxisorp microtiter plate was coated with C. jejuni
WCA (1 × 108 cfu/well) and 2.8 × 105 phages were used
in each well. Bound phages were detected by HRP-
conjugated ant i -M13 monoclonal ant ibody (GE
Healthcare) and its substrate ABTS. Phage clones which
showed high binding activity to C. jejuni cells were also
tested for reaction with non-irradiated C . jejuni ,
Campylobacter coli, and Campylobacter lari and three
other unrelated foodborne pathogens, L. monocytogenes,
S. Typhimurium, and E. coli by ELISA, as described
above.
Expression and purification of anti-C. jejuni scFv
monoclonal antibodies
Clones scFv61 and scFv80, shown by ELISA to have the
highest binding specificity, were chosen to express soluble
anti-C. jejuni scFv antibodies. The phagemid DNAwas puri-
fied from E. coli ER2738 and transformed into non-
suppressor E. coli TOP10F′ cells (Invitrogen). Transformants
were confirmed by colony PCR, as described above.
A single colony was inoculated into 10 ml pre-warmed
super broth (SB) medium containing 50μg/ml of carbenicillin
and cultured overnight at 37 °C. The overnight culture was
diluted 1:50 into fresh SB supplemented with 50 μg/ml
carbenicillin and 40 mM MgCl2. The culture was incubated
for 6 h at 37 °C with shaking at 250 rpm. Expression of the
scFv antibodies was induced by adding isopropyl β-D-1-thio-
galactopyranoside (IPTG) to a final concentration of 1 mM.
The expression was induced for 18 h at 37 °C with shaking at
250 rpm. The culture was harvested by centrifuging at 3000 g
for 30 min at 4 °C. The pellet was resuspended in 30–40 ml
ice-cold extraction buffer containing 1× PBS, 1× Complete
Cocktail Protease Inhibitor, 6.4 mM phenylmethylsulfonyl
fluoride (PMSF), 5 mM MgCl2, 0.05 mg/ml DNase 1, and
0.05% β-mercaptoethanol. Cells were lysed by six French
Press cycles at 1000 psi at 4 °C. The cleared lysate was cen-
trifuged at 20,100 g for 30 min at 4 °C. The His-tagged scFv
antibody in the supernatant was purified by adding 2 ml
HisPur Ni-NTA Resin (Thermo Scientific), in the presence
of imidazole. Binding was performed at 4 °C for 2 h with slow
rotation. The beads were harvested by centrifuging at 2000 g
for 5 min at 4 °C, washed twice in 50 ml ice-cold PBS
containing imidazole for 10 min at 4 °C. The washed beads
were resuspended into 2 ml of ice-cold PBS with high con-
centrations of imidazole and incubated for 15 min at 4 °C with
gentle shaking. After a final centrifugation at 2000 g for 5 min
at 4 °C, the supernatant containing the eluted antibody was
aliquoted and stored at − 80 °C.
Presence of the scFv antibodies was checked by Western
blotting. Protein samples were resolved by 15% SDS-PAGE
before they were transferred onto Protran 0.2 NC nitrocellu-
lose blotting membrane (Amersham). The membrane was
blocked with a buffer consisting of 25 mM Tris pH 7.2,
0.15 M NaCl, 0.025% Tween-20, and 1% BSA for 1 h before
being washed twice in TBS with 0.025% Tween 20. The His-
tagged scFv was detected by incubating the membrane in
1:5000 dilution of India HisProbe-HRP (Thermo Scientific)
in blocking buffer. After four washes with TBS containing
0.025% Tween 20, the membrane was incubated in
SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific), exposed to X-ray film, and then
developed.
Characterization of soluble scFv80 antibody
The concentration of purified anti-C. jejuni scFv80 antibody
was estimated by an ELISA assay, using His-tagged Cardiac
Troponin I (cTnI) (GenScript) as the standard. Antigen-
recognition capability and specificity of scFv80 for C. jejuni
was then assessed by ELISA. A 96-well Nunc-Maxisorp mi-
crotiter plate was coated overnight at 4 °C with non-irradiated
C. jejuni and five other non-target bacterial cells (108 cfu/
well). The plate was washed twice with 200 ml of TBS con-
taining 0.05% Tween 20 (0.05% of PBS/Tween 20) and
blocked with 200 ml of 1% BSA in PBS at 37 °C. After
washing the plate twice with 0.05% of PBS/Tween 20,
100 μl scFv80 antibody (200 ng/ml) was added to each well,
while PBS was added to control wells. The plate was incubat-
ed for 2 h at 37 °C with shaking and then washed three times
with 0.05% of PBS/Tween 20. Bound scFv80 antibody was
detected by adding 100 μl HisProbe-HRP conjugate
(1:50,000 diluted in TBS containing 0.05% Tween 20) per
well and incubating for 1 h at room temperature with
shaking. Following four washes with 0.05% of PBS/
Tween 20, 100 μl TMB(E) was added to each well, incu-
bated at room temperature for 5 min, and then stopped
with 25 μl 1 M H2SO4. Colorimetric signal was read at
450 nm using a plater reader.
Development of an automated IMS procedure
for capturing C. jejuni using anti-C. jejuni scFv80
BcMag™ long-arm and short-arm tosylactivated magnetic
beads (10 mg each) (Bioclone Inc., San Diego) were covalent-
ly coated with 200 μg of purified scFv80 following the bead
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manufacturer’s instructions. To determine the capture capabil-
ity and sensitivity of the coated beads, five ten-fold dilutions
of non-irradiated C. jejuni cells (containing 107–103 cfu/ml)
were processed by IMS, performed using a Dynal
BeadRetriever instrument (Invitrogen). Each 1 ml dilution
was mixed with 10 μl of coated beads (containing around
1.7 × 107 beads) for 30 min, followed by two 1-min washes
in PBS-0.05% Tween 20. The washed beads were resuspend-
ed in 100 μl TE buffer, pH 8.0, and heated at 99 °C for 10 min
in a heating block to release DNA from any bound C. jejuni
cells. The tubes were centrifuged for 2 min at 21,800 g to
sediment beads and cell debris leaving DNA in the superna-
tant. C. jejuni DNA in the supernatant was quantified by
qPCR. Subsequently, to evaluate the specificity of the IMS
process, IMS was repeated to capture C. jejuni cells from a
mixed sample containing C. jejuni, C. coli, and C. lari (each
present at 104 cfu/ml), before quantification of the capturedC.
jejuni, C. coli, and C. lari by qPCR. C. jejuni was quantified
by qPCR targeting the hipOa gene (Keramas et al. 2003) using
p r im e r s CGTGCAGATATGGATGCTTTG and
TGCAGCAAGCAATAAAGAAGTAG. C. coli was quanti-
fied by qPCR targeting the glyAb gene (Vondrakova 2014)
using primers GCGAGTGCTTATGCTCGTATTA and
CCAGCAATGTGTGCAATGTC. C. lari was quantified by
qPCR targeting the pepTc gene (Vondrakova 2014) using
primers GAGCTGATGATAAAGCTGCTATTG and
CACCTCTTAGGCCTTGTTCTT. All of the qPCR reactions
were performed in triplicate. Input and captured cells were
quantified against standard curves and % recovery of cells
by IMS was calculated.
Results
Successful immunization of rabbits with C. jejuni
whole cell antigen and construction of scFv phage
display library
After the immunization course was completed for two New
Zealand White rabbits, a substantial increase in anti-C. jejuni
IgG production was observed in one of the rabbits (Fig. S1;
Fig. 1a) and spleen and bonemarrowwere harvested from this
rabbit. Total RNA extracted from the spleen (Fig. 1b) was
used to synthesize the first-strand complementary DNA
(cDNA) from which individual VL- and VH-chain region
genes of approximately 350 and 400 bp, respectively, were
amplified by PCR (Fig. S1, S2; Fig. 1c). The VL and VH
chains were randomly joined by overlap extension PCR
through a linker sequence to construct the 800 bp cDNA
encoding full-length scFv fragments (Fig. S1, Fig. 1d).
Following digestion with SfiI, scFv constructs of approxi-
mately 750 bp in size were ligated into the SfiI sites of a 3.4 kb
linearized, dephosphorylated pComb3XSS phagemid vector.
A library of phage particles displaying scFv on the surface,
comprised of 6.8 × 107 independent transformants, was pro-
duced by successful transformation of the ligation into E. coli
ER2738 electrocompetent cells and rescuing the library by
infecting with helper phage M13 K07. The efficiency of li-
brary construction, determined by randomly selecting 93 col-
onies from the titered library and performing colony PCR,
showed that the positive rate of transformants containing
cDNA in the phagemid was 96%.
Screening and characterization of scFv-displaying
particles which can strongly and specifically recognize
C. jejuni cells
After six rounds of biopanning, including double recognition
in first round, the effectiveness of the enrichment in phage
pools from different rounds was verified by indirect phage-
binding ELISA assay (Fig. 2a). The unpanned library showed
slight signal compared to the control phage that did not dis-
play scFv, demonstrating that the constructed library
contained phage clones that recognized C. jejuni WCA.
However, no significant enrichment of antibodies was found
in phage pools after three rounds of biopanning. Progression
in enrichment of positive phage clones was detected gradually
with increase in stringency of washes and once high stringen-
cy washing was adopted from round 4 to round 6, an 8.5-fold
enrichment of phage particles in phage pools was achieved,
demonstrated by an increase in OD415 from 0.2 to1.7.
One hundred thirty-five individual clones randomly select-
ed from titered output phages after round 6 were checked for
diversity of the scFv cDNA sequences by PCR followed by
digestion with restriction enzyme Mva I. Analysis of the di-
gestion patterns revealed 47 unique groups (data not shown).
A representative clone from each group was analyzed for
binding activity and specificity to freshly prepared (non-
irradiated) C. jejuni, C. coli, and C. lari WCAs using phage
ELISA. Clones with signals at least two times greater than that
of the empty vector control were considered to be binding
Campylobacter cells. This testing revealed 12 clones which
strongly recognized C. jejuni (Fig. S3); 3 of which (61, 80,
and 191, from different Mva I digestion groups) specifically
recognized C. jejuni and not the other 2 Campylobacter spp.
(C. coli and C. lari) (Fig. 2b) or other unrelated foodborne
pathogens (L. monocytogenes, S. Typhimurium, and E. coli)
(Fig. 2c) tested.
Expression and purification of anti-C. jejuni scFv
monoclonal antibodies
Clones scFv61 and scFv80 were selected for expression of
antibody fragments not fused to phage particles.
Recombinant pComb3XSS phagemid DNA of scFv61 and
scFv80 was isolated from E. coli ER2738 cells, transformed
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into TOP10F′ cells (a nonsuppressor strain of E. coli) and
confirmed by colony PCR. The transformed TOP10F′ cells
were induced by IPTG to produce a protein band of ~
30 kDa in total protein fractions of both scFv61 and scFv80
as revealed by Western blotting (Fig. 3a), demonstrating suc-
cessful expression of both antibodies. However, only scFv80
was shown to be expressed in a soluble form, as shown by the
presence of the ~ 30 kDa protein band in the total soluble
fraction of scFv80 but not that of scFv61.While both antibod-
ies were fused with a poly histidine tag (His6-tag) at the C-
terminus, the presence of a ~ 30 kDa band in the captured
fraction of scFv80 only clearly shows that the soluble
scFv80 protein readily bound to Ni-NTA resin and was
successfully eluted. In contrast, absence of protein band
in the captured fraction of scFv61 confirmed that it was
expressed as insoluble protein, which could not be cap-
tured by beads.
To maximize the purity of the scFv80 when using HisPur
Ni-NTA affinity Resin, concentration of imidazole in binding,
washing, and elution buffers was optimized. Increasing the
Fig. 1 Successful immunization of a rabbit with C. jejuni WCA and
amplification of scFv cDNA fragments from spleen of the rabbit. a
ELISA signal against C. jejuni cells, using pre-bleed and antisera from
the rabbit after two (T2), three (T3), four (T4), and five (T5)
immunizations. Each column represents the mean fold difference in
ELISA signal from pre-bleed. The error bars represent standard
deviation of the signals in the triplicate wells for each antibody. b
Agarose gel image of the three total RNA samples purified from the
spleen of the rabbit immunized with C. jejuni WCA. The sharp rRNA
bands show that the RNA samples had no degradation. c Agarose gel
image of purified cDNA fragments for VH and VL chains amplified from
immune rabbit spleen. PCR products using nine pairs of VK and 1 pair of
Vλ primers were pooled together to purify the VL fragment. PCR products
using four pairs of VH primers were pooled together to purify the VH
fragment. LaneM = 100 bp ladder; bp size of some bands is shown on the
left of the image. Lane 1 = ~ 450 bp VH cDNA, lane 2 = ~ 350 bp VL
cDNA. d Agarose gel image of purified full-length scFv cDNA fragment
after merging the VL and VH fragments by overlap extension PCR. Lane
M = 100 bp ladder. Lane 1 = ~ 800 bp scFv cDNA fragment, lane 2 =
non-template PCR control
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concentration of imidazole in the binding buffer to 50 mM
was observed to give the highest stringency with optimum
binding of scFv80 to the beads, while 100 mM of imidazole
significantly reduced capturing of the antibody (Fig. 3b).
Analysis of the impact of different concentrations of imidazole
(50, 100, 150, and 200 mM) in the washing buffer after bind-
ing scFv80 antibody in 50 mM of imidazole showed that
washes in 50 mM imidazole retained the highest yield of
scFv80 on beads, whereas imidazole concentrations above
50 mM significantly washed off the antibody from the beads
(Fig. 3c). Elution efficiency of scFv80 antibody in elution
buffer containing 150, 250, 500, or 750mMof imidazole from
beads that had been bound and washed with the optimized
50 mM imidazole respectively showed that elution efficiency
increased significantly from 150 to 250 mM of imidazole
and no further significant increase in elution efficiency
was observed beyond 250 mM of imidazole (Fig. 3d).
Therefore, the optimal concentrations of imidazole for
producing pure levels of scFv80 antibody were 50 mM
in binding buffer, 50 mM in washing buffer, and 250 mM
in elution buffer.
Binding characteristics of purified anti-C. jejuni
scFv80 antibody to bacterial cells
A large-scale culture of scFv80 antibody was purified using
the optimized imidazole concentrations. The concentration of
purified scFv80 was estimated to be 180 ng/μl by ELISA
using commercial His-tagged cTnI as a standard. The purified
scFv80 antibody was tested for its binding specificity to C.
jejuni and other non-target bacteria in an ELISA assay. This
assay clearly demonstrated that the purified scFv80 specifical-
ly recognized C. jejuni cells but did not bind to either its
relatives (C. coli and C. lari), or the three other unrelated
foodborne pathogens (E. coli, S. Typhimurium, or L.
monocytogenes), even though these cells were exposed to
the antibody at a high concentration of 1 × 108 cells/well
(Fig. 4a).
Evaluation of purified scFv80 in IMS procedure
to capture C. jejuni cells
The capacity of purified scFv80 antibody as a ligand to cap-
ture C. jejuni cells by IMS was tested using long-arm and
short-arm BcMag™ tosylactivated paramagnetic beads that
had been covalently coated with the antibody. The captured
cells were quantified by qPCR.When sensitivity of the IMS in
recovering C. jejuni cells from samples containing 103 to 107
cells/ml was assessed, both long-arm and short-arm
tosylactivated beads coated with scFv80 were found to be able
to capture 100% of C. jejuni cells from dilutions containing
103 to 104 cells/ml (Fig. 4b). It was observed that when the cell
input was higher than 104 cells/ml, the recovery rate of C.
Fig. 2 Enrichment of C. jejuni-binding scFv-displaying phages by
biopanning and characterization of selected phage clones for binding
specificity. In a–c equal amount of cells and phage particle were used in
each experiment. The bound phage particles were detected using HRP-
conjugated anti-M13 antibody and the substrate ABTS. a ELISA assay to
test binding activity to C. jejuni cell, using scFv-displaying phage pools
that resulted from different rounds of biopanning. The control phage is the
non-displaying phage. Signal reading at 415 nm is shown in the Y-axis. b
The three best scFv-displaying phage clones (scFv 61, scFv 80, scFv 191)
were tested in ELISA assay for their binding activity toC. jejuni and other
Campylobacter spp. c The three best scFv-displaying phage clones were
tested in ELISA assay, comparing their binding activity to C. jejuni and
three non-Campylobacter bacterial cells. In b, c, the signal reading at
415 nm of the cell-coated wells was normalized against that in the
uncoated wells. Each column and error bar in a–c represents the mean
and standard deviation of triplicates of reactions
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jejuni by the beads decreased, ranging from 16 to 60%
(Fig. 4b), which suggested that the coated beads had amaximum
binding capacity.
In biological samples,C. jejuni could be present along with
other cells, so to test if scFv80-coated beads could specifically
recover C. jejuni from mixed cell suspensions, IMS was per-
formed on a sample containing C. jejuni, C. lari, and C. coli,
all at 104 cells/ml. Recovered cells were quantified by qPCRs
targeting genes specific to C. jejuni, C. lari, and C. coli.
Figure 4c shows that in this IMS, the short-arm beads recov-
ered 100% C. jejuni, whereas the long-arm beads recovered
82%. The short-arm scFv80-coated beads performed better
than long-arm scFv80-coated beads, although both beads
were very specific for C. jejuni, capturing only 1.5–4% of
either C. coli or C. lari cells.
Discussion
Campylobacteriosis, especially caused by C. jejuni, is the
most common bacterial cause of human gastroenteritis world-
wide (Silva et al. 2011; Tram et al. 2012). Poultry is the main
reservoir of C. jejuni (Skarp et al. 2016) and most human
infections are caused by consuming undercooked poultry or
mishandling of contaminated poultry products (Silva et al.
2011). Effective monitoring of C. jejuni in chickens prior to
slaughter is crucial to tackling Campylobacteriosis, but better
detection methods are urgently needed for this purpose.
Here, we present the results of construction of a scFv-
phage displaying library derived from a C. jejuni immunized
rabbit, and selection of phage clones displaying scFv antibod-
ies recognizing C. jejuni cell by phage display biopanning. In
addition, we describe development of an IMS method
employing one of the C. jejuni-specific scFv antibodies pro-
duced, to capture and concentrate C. jejuni from test samples.
This IMS method was subsequently combined with a qPCR
method to achieve rapid detection and quantitation of C.
jejuni. We demonstrate that the resultant IMS-qPCR method
could potentially be suitable for C. jejuni monitoring pur-
poses, subject to some further optimization.
In order to produce novel recombinant scFv antibodies
specific for C. jejuni cells, two rabbits were immunized with
C. jejuni whole cells that had been subjected to gamma radi-
ation rather than heat-inactivation before use. Irradiation kills
the bacterial cells while maintaining the integrity of cell sur-
face antigens, unlike heating which is liable to denature some
Fig. 3 Expression and
purification of C. jejuni-specific
scFv antibodies. aWestern blot of
scFv61 and scFv80, expressed in
E. coli and captured by affinity
beads. Both antibodies have
6xHis tag at their C-terminus and
were detected using His-probe.
Nickel beads were used to capture
the soluble antibodies. b Western
blot of scFv80 expressed and
purified using different imidazole
concentrations in the binding
buffer. c Western blot of scFv80
expressed and purified using
different imidazole
concentrations in the washing
buffer. d Western blot of scFv80
expressed and purified using
different imidazole
concentrations in the elution
buffer
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or all of these surface antigens (Stewart et al. 2012). Once a
high serum antibody titer againstC. jejuni had been reached in
one of the immunized rabbits, indicating that there was enrich-
ment for antigen-specific antibodies, the rabbit spleen was
harvested for RNA extraction. Either spleen or bone marrow
from the immune-responsive rabbit could have been selected
as the starting point for recombinant antibody production. We
selected spleen as our starting material because for high titer
animals, like the one in this study, it has been shown that V
genes encoding antigen-specific antibodies dominate the large
Fig. 4 Purified scFv80 antibody
specifically recognizes C. jejuni
cells. a In the ELISA assay,
purified scFv80 was used to
detect C. jejuni and other
foodborne pathogens. The same
amount of bacterial cells and
scFv80 antibody was used in all
the ELISAwells. Bound scFv80
was detected by HisProbe-HRP
Conjugate and the substrate TMB
(E). Signal read at 450 nm was
shown in the Y-axis. Each column
represents the mean and standard
deviation of signals in three wells.
b Recovery of C. jejuni by IMS
from solutions containing
different cell concentrations (103–
107 cfu/ml) using scFv80 coated
beads. Cell concentrations are
labeled below each column.
Recovery was calculated
according to qPCR quantification
data of the captured and input
cells. c Recovery of
Campylobacter cells by IMS
using scFv80 coated beads from a
mixed culture ofC. jejuni,C. coli,
and C. lari (each present at
104 cfu/ml). qPCR reactions
specific to C. jejuni, C. coli, or C.
lari were used to quantify the
input and captured cells before
calculating the recovery rate of
each species
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diverse B lymphocytes in the spleen indicating that total
splenocytes can be used in place of bone marrow plasma cells
for antibody discovery (Saggy et al. 2012). The VL and VH
chain genes were separately amplified from the spleen cDNA
along with the short linker sequence through which the indi-
vidual cDNA fragments were randomly joined by overlap
extension PCR to produce full-length scFv cDNA fragments
(Barbas et al. 2001). The short linker joining VH and VL in
scFv maintains the antigen-binding sites, with enhanced avid-
ity for the specific antigen, as previously noted by Turner et al.
(1997) and Singh et al. (2010). According to Barbas et al.
(2001), the isolation of specific antibodies from a cloned im-
munological repertoire requires a large, diverse, and complex
library in the range of 107 to 108 independent transformants,
as well as an efficient selection process. In this study, when
cloned into the phagemid vector pComb3XSSwhich had been
dephosphorylated in order to increase the proportion of
transformants containing the cDNA fragments, the scFv genes
resulted in a combinatorial library with 6.8 × 107 clones. This
was considered to have sufficient complexity to proceed to
phage display. The scFv antibodies were expressed as fu-
sions to the gene III coat protein (pIII) of the phage surface,
as first described by Smith (1985), which made it possible
for them to be screened by successive rounds of biopanning
against the C. jejuni WCA (Barbas et al. 2001) to enrich
clones expressing scFv antibodies strongly recognizing
C. jejuni cells.
ELISA analysis of the outcome phages of the first three
rounds of biopanning did not show significant enrichment of
C. jejuni binders (Fig. 2a). However, some evidence of enrich-
ment began to be observed after round 4, doubled after round
5, and then showed a marked increase after round 6 (Fig. 2a).
As the stringency of the selection conditions increased with
successive rounds of biopanning, more scFv-displaying phage
clones with better binding capabilities were successfully se-
lected, resulting in library enrichment at round 6 of
biopanning. After round 6, 135 clones were randomly selected
to amplify the scFv cDNA and subjected to Mva I restriction
digestion; the digestion patterns were used to quickly test se-
quence diversity of scFv cDNA among the large numbers of
clones (Barbas et al. 2001).
Two phage clones, 61 and 80, were selected to express
scFv antibodies without pIII. pComb3XSS contains the amber
codon such that when transformed into a non-suppressor bac-
terial strain, it can express soluble protein without coat protein
III (Barbas et al. 2001). These scFv antibodies are fused with a
poly histidine tag (His6-tag) and hemagglutinin tag (HA-tag)
at their C-terminus which aids affinity purification and
immuno-detection of the antibody proteins by Western blot-
ting. Phagemid DNA isolated from clones 61 and 80 was
transformed into the non-suppressor E. coli TOP10F′ cells.
Protein expression was induced by IPTG at 37 °C for 18 h.
scFv80 was expressed as a soluble protein (Fig. 3a); a pure,
single scFv80 protein band, of size ~ 30 kDa, was observed on
SDS-PAGE gel and by Western blotting. In contrast, scFv61
was expressed as an insoluble protein. The high-level expres-
sion of scFv61 in TOP10F′ cells may have led to formation of
highly aggregated protein commonly referred to as inclusion
bodies (Palmer and Wingfield 2012), resulting in it being in-
soluble. Several alternative strategies to generate soluble
scFv61 were tried, including expressing the protein at varying
temperatures in TOP10F′ cells, supplementing with glucose
and sorbitol, and expression in a different non-suppressor
strain, E. coli BL-21-A in the presence of 0.2% (w/v) arabi-
nose, but all have proved unsuccessful to date.
The specificity of the purified, soluble C. jejuni-specific
scFv80 antibody was assessed by ELISA. The recombinant
antibody was confirmed to have retained its high binding ca-
pability for C. jejuni WCAwhen not expressed on the phage
and it still did not cross-react with two other Campylobacter
spp. or three other unrelated foodborne bacterial pathogens
(Fig. 4a). These results indicated that scFv80was very specific
forC. jejuni and, hence, potentially suitable to be incorporated
into a novel detection approach for this foodborne pathogen.
IMS linked with qPCR was our novel detection approach of
choice because IMS offers the possibility of selectively
extracting C. jejuni cells from heterogeneous suspensions,
such as those that are encountered in food, clinical specimens,
and feces, and qPCR offers the possibility of rapid, specific,
and quantitative detection of the captured C. jejuni cells as-
suming appropriate primers are selected. Therefore, purified
scFv80 antibody was coated onto tosylactivated magnetic
beads and suitable primers were selected/designed for qPCR
detection; targeting the HipO gene, encoding hippuricase, that
is absent in all Campylobacter species except C. jejuni
(Keramas et al. 2003), and the glyA and pepT genes in C.
coli and C. lari, respectively (Vondrakova 2014).
Immunomagnetic separation has been successfully used to
capture foodborne Salmonella spp. and Listeria monocytogenes
using beads coated with phage display-derived peptides
(Carnazza et al. 2007; Morton et al., 2013a, b), or beads coated
with a phage display-derived single-chain antibody for Listeria
monocytogenes (Paoli et al. 2007). IMS methods for C. jejuni
involving polyclonal andmonoclonal antibodies have previous-
ly been reported (Yu et al. 2001; Tram et al. 2012). To our
knowledge, this study is the first to assess the IMS potential
of a recombinant scFv antibody specific forC. jejuni. The novel
recombinant scFv80 antibody was evaluated for IMS by coat-
ing two types of tosylactivated paramagnetic beads (‘short-arm’
and ‘long arm’); these were both shown to be capable of cap-
turing 100% C. jejuni cells from a pure culture containing 1000
to 10,000 cfu/ml (Fig. 4b). We did not test recovery of cells
below 1000 cfu/ml. However, we have tested the sensitivity of
the qPCR step and found that it can detect as low as five cells
(data not shown). Therefore, we are confident the limit of de-
tection (LOD) of the IMS can be further reduced. Percentage
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recovery from high concentrations of C. jejuni by the IMS was
low (Fig. 4b). However, this is not an issue in terms of potential
application of the beads in real life sample because rarely would
biological samples have such high levels of C. jejuni present.
The long- and short-arm beads both specifically and selectively
captured 82 and 100% C. jejuni cells, respectively, from a
mixed suspension containing 10,000 cfu/ml of each of C.
jejuni, C. coli, and C. lari (Fig. 4c). In this study, 1 ml of cell
samples was used in IMS. However, real biological samples are
often in volumes of 50 to 250ml. A centrifugation step could be
introduced to concentrate the cells into 1 ml before applying the
IMS to this concentrated sample. This experiment demonstrated
that the IMS procedure using recombinant monoclonal scFv80
antibody derived from the spleen of a C. jejuni immunized
rabbit specifically captured C. jejuni. To our knowledge, our
work represents the first attempt to use recombinant scFv anti-
bodies in IMS for capturing Campylobacter spp. to date. The
IMS-qPCR method was able to specifically detect 1000 cfu/ml
C. jejuni in just under 3 h.With some further optimization of the
IMS, it may be possible to improve on the detection sensitivity.
In conclusion, a novel anti-C. jejuni recombinant scFv an-
tibody, scFv80, demonstrating strong and specific binding to
C. jejuni cells was successfully generated from an immune
spleen combinatorial library by phage display. When this nov-
el recombinant monoclonal scFv80 antibody was coated onto
BcMag™ long-arm and short-arm tosylactivated magnetic
beads, and IMS was carried out in combination with qPCR
as the endpoint detection method, the resultant IMS-qPCR
assay indicated the specific capture of 82–100% C. jejuni
cells, from a mixed culture containing C. jejuni, C. coli, and
C. lari. The scFv80 antibody-based IMS-qPCRmethodmerits
further development and optimization, as it could potentially
reduce the current detection time for C. jejuni from 3 to 5 days
to just under 3 h without the need for a culture enrichment
step.
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